Abbott Laboratories Company Profile (NYSE:ABT)

About Abbott Laboratories

Abbott Laboratories logoAbbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a line of healthcare products. The Company operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment includes the sales of a line of adult and pediatric nutritional products. The Nutritional Products includes the sales of diagnostic systems and tests for blood banks, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products. Its Established Pharmaceutical Products segment's therapeutic area portfolio of products includes gastroenterology products, women's health products, and respiratory drugs and vaccines.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: ABT
  • CUSIP: 00282410
Key Metrics:
  • Previous Close: $42.84
  • 50 Day Moving Average: $43.74
  • 200 Day Moving Average: $40.71
  • Trailing P/E Ratio: 28.23
  • Foreward P/E Ratio: 17.47
  • P/E Growth: 2.08
  • Market Cap: $62.87B
  • Outstanding Shares: 1,469,995,000
  • Beta: 0.74
Additional Links:
Companies Related to Abbott Laboratories:

Analyst Ratings

Consensus Ratings for Abbott Laboratories (NYSE:ABT) (?)
Ratings Breakdown: 6 Hold Ratings, 15 Buy Ratings
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $47.07 (9.52% upside)

Analysts' Ratings History for Abbott Laboratories (NYSE:ABT)
DateFirmActionRatingPrice TargetDetails
8/12/2016Bank of America Corp.Reiterated RatingBuy$50.00View Rating Details
8/10/2016BTIG ResearchReiterated RatingBuy$45.00View Rating Details
8/9/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
8/4/2016Jefferies GroupBoost Price TargetBuy$49.00 -> $52.00View Rating Details
7/28/2016ArgusReiterated RatingBuy$55.00View Rating Details
7/21/2016Barclays PLCBoost Price TargetOverweight$48.00 -> $50.00View Rating Details
6/21/2016Edward JonesUpgradeHold -> BuyView Rating Details
6/8/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details
5/12/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
5/2/2016BMO Capital MarketsReiterated RatingBuyView Rating Details
4/30/2016S&P Equity ResearchReiterated RatingHoldView Rating Details
4/30/2016GabelliReiterated RatingBuyView Rating Details
4/28/2016Piper Jaffray Cos.DowngradeOverweight -> NeutralView Rating Details
4/21/2016Cowen and CompanyReiterated RatingNeutral -> Buy$44.00 -> $48.00View Rating Details
4/14/2016First GlobalDowngradeOutperform -> MarketperformView Rating Details
4/11/2016Royal Bank Of CanadaReiterated RatingOutperform$45.00 -> $48.00View Rating Details
3/28/2016Stifel NicolausBoost Price TargetBuy$42.00 -> $47.00View Rating Details
3/28/2016Leerink SwannBoost Price TargetMarket Perform$37.00 -> $40.00View Rating Details
1/29/2016Raymond James Financial Inc.Lower Price TargetOutperform$46.00 -> $42.00View Rating Details
1/29/2016Goldman Sachs Group Inc.Lower Price TargetNeutral$44.00 -> $40.00View Rating Details
1/29/2016William BlairDowngradeOutperform -> Market PerformView Rating Details
1/4/2016Morgan StanleyDowngradeOverweight -> Equal Weight$50.00View Rating Details
5/27/2015Evercore Partners Inc.Initiated CoverageBuy$54.00View Rating Details
5/26/2015Evercore ISIInitiated CoverageBuy$54.00View Rating Details
4/23/2015JPMorgan Chase & Co.Boost Price TargetNeutral$46.00 -> $48.00View Rating Details
(Data available from 8/26/2014 forward)


Earnings History for Abbott Laboratories (NYSE:ABT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/20/2016Q216$0.53$0.55$5.24 billion$5.30 billionViewListenView Earnings Details
4/20/2016Q116$0.39$0.41$4.77 billion$4.90 billionViewListenView Earnings Details
1/28/2016Q415$0.61$0.62$5.31 billion$5.20 billionViewListenView Earnings Details
10/21/2015Q315$0.53$0.54$5.16 billion$5.15 billionViewListenView Earnings Details
7/22/2015Q215$0.50$0.52$5.15 billion$5.20 billionViewListenView Earnings Details
4/22/2015Q115$0.42$0.47$4.85 billion$4.90 billionViewListenView Earnings Details
1/29/2015Q414$0.69$0.71$5.48 billion$5.36 billionViewListenView Earnings Details
10/22/2014Q314$0.59$0.62$5.62 billion$5.10 billionViewListenView Earnings Details
7/16/2014Q214$0.51$0.54$5.53 billion$5.55 billionViewListenView Earnings Details
4/16/2014Q114$0.36$0.41$5.29 billion$5.24 billionViewListenView Earnings Details
1/22/2014Q413$0.58$0.58$5.72 billion$5.66 billionViewListenView Earnings Details
10/16/2013Q313$0.52$0.55$5.46 billion$5.37 billionViewListenView Earnings Details
7/17/2013Q2 2013$0.44$0.46$5.53 billion$5.45 billionViewListenView Earnings Details
4/17/2013Q1 2013$0.41$0.42$5.42 billion$5.38 billionViewListenView Earnings Details
1/23/2013Q4 2012$1.50$1.51$10.58 billion$10.80 billionViewListenView Earnings Details
10/17/2012$1.28$1.30ViewN/AView Earnings Details
7/18/2012$1.22$1.23ViewN/AView Earnings Details
4/18/2012$1.00$1.03ViewN/AView Earnings Details
1/25/2012$1.44$1.45ViewN/AView Earnings Details
10/19/2011$1.17$1.18ViewN/AView Earnings Details
7/20/2011$1.12$1.12ViewN/AView Earnings Details
4/20/2011$0.90$0.91ViewN/AView Earnings Details
1/26/2011$1.29$1.30ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Abbott Laboratories (NYSE:ABT)
Current Year EPS Consensus Estimate: $2.20 EPS
Next Year EPS Consensus Estimate: $2.46 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.39$0.40$0.39
Q2 20165$0.51$0.54$0.53
Q3 20163$0.58$0.60$0.59
Q4 20162$0.66$0.67$0.67
Q1 20173$0.44$0.51$0.47
Q2 20172$0.60$0.61$0.61
Q3 20172$0.63$0.63$0.63
Q4 20172$0.70$0.71$0.71
Q1 20181$0.51$0.51$0.51
(Data provided by Zacks Investment Research)


Current Dividend Information for Abbott Laboratories (NYSE:ABT)
Annual Dividend:$1.04
Dividend Yield:2.42%
Payout Ratio:68.87% (Based on Trailing 12 Months of Earnings)
47.27% (Based on Current Year Consensus EPS Estimate)
42.28% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:-21.80% (3 Year Average)

Dividend History for Abbott Laboratories (NYSE:ABT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Abbott Laboratories (NYSE:ABT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/28/2016Stephen R FussellInsiderSell41,500$45.00$1,867,500.00View SEC Filing  
7/26/2016Michael J WarmuthInsiderSell26,800$43.49$1,165,532.00View SEC Filing  
7/25/2016Miles D WhiteChairmanBuy242,547$43.18$10,473,179.46View SEC Filing  
7/25/2016Robert E FunckVPSell26,800$43.08$1,154,544.00View SEC Filing  
6/28/2016Hubert L AllenEVPSell3,400$37.14$126,276.00View SEC Filing  
6/15/2016Jared WatkinSVPSell552$37.63$20,771.76View SEC Filing  
6/1/2016Brian B YoorCFOSell565$39.49$22,311.85View SEC Filing  
4/28/2016Deepak S NathSVPSell53$41.31$2,189.43View SEC Filing  
3/31/2016Jaime ContrerasSVPSell462$41.78$19,302.36View SEC Filing  
2/29/2016Brian B YoorCFOSell865$39.12$33,838.80View SEC Filing  
2/29/2016Deepak S NathSVPSell793$39.27$31,141.11View SEC Filing  
2/29/2016Robert B FordEVPSell1,706$39.28$67,011.68View SEC Filing  
2/29/2016Robert E FunckVPSell1,333$39.30$52,386.90View SEC Filing  
2/22/2016Jared WatkinSVPSell554$39.09$21,655.86View SEC Filing  
2/16/2016Deepak S. NathSVPSell171$37.13$6,349.23View SEC Filing  
12/16/2015Miles D. WhiteCEOSell438,000$46.00$20,148,000.00View SEC Filing  
8/18/2015Stephen R. FussellEVPSell13,096$50.46$660,824.16View SEC Filing  
4/27/2015Heather L MasonEVPSell13,500$47.45$640,575.00View SEC Filing  
4/27/2015Roger BirdSVPSell28,548$47.57$1,358,028.36View SEC Filing  
3/26/2015J. Scott WhiteSVPSell12,483$46.68$582,706.44View SEC Filing  
3/2/2015Jaime ContrerasSVPSell9,209$47.34$435,954.06View SEC Filing  
2/4/2015John M CapekEVPSell34,292$45.66$1,565,772.72View SEC Filing  
11/25/2014Jaime ContrerasSVPSell51,600$44.07$2,274,012.00View SEC Filing  
10/29/2014Miles D WhiteCEOSell440,800$42.52$18,742,816.00View SEC Filing  
3/3/2014John LandgrafEVPSell17,293$39.38$680,998.34View SEC Filing  
3/3/2014Katherine DoyleSVPSell6,639$39.01$258,987.39View SEC Filing  
3/3/2014Robert FunckVPSell1,413$38.97$55,064.61View SEC Filing  
2/18/2014John LandgrafEVPSell1,583$39.10$61,895.30View SEC Filing  
1/29/2014Michael WarmuthEVPSell11,430$36.21$413,880.30View SEC Filing  
12/6/2013Jean-Yves PaveeSVPSell5,855$37.46$219,328.30View SEC Filing  
11/7/2013Stephen FussellEVPSell10,466$37.59$393,416.94View SEC Filing  
10/30/2013Jaime ContrerasSVPSell25,368$36.85$934,810.80View SEC Filing  
6/7/2013Heather L MasonSVPSell12,000$37.01$444,120.00View SEC Filing  
2/1/2013William A OsbornDirectorBuy10,000$33.86$338,600.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Abbott Laboratories (NYSE:ABT)
News IconNotable Hot Runners: Abbott Laboratories (NYSE:ABT), Exelixis, Inc. (NASDAQ:EXEL) - NYSE Journal (press release) (NYSE:ABT) - August 26 at 3:15 PM logoAlere Sues Abbott Laboratories to Force Merger - Wall Street Journal (NYSE:ABT) - August 26 at 3:15 PM logoOptions Bears Blitz St. Jude Medical, Inc. (STJ), Abbott Laboratories (ABT) - Schaeffers Research (blog) (NYSE:ABT) - August 26 at 3:15 PM logoAlere sues Abbott over $5.8 bln takeover (NYSE:ABT) - August 26 at 3:15 PM logo[$$] Alere Sues Abbott to Force Merger (NYSE:ABT) - August 26 at 3:15 PM logoBRIEF-Abbott Laboratories says "Alere's lawsuit is without merit" (NYSE:ABT) - August 26 at 12:53 PM logoSt. Jude Medical drops after Muddy Water findings of 'negligent product design' (NYSE:ABT) - August 25 at 8:41 PM
News IconTraders Watch List - Delta Air Lines (NYSE:DAL), Abbott Laboratories (NYSE:ABT) - Money News (press release) (NYSE:ABT) - August 25 at 3:15 PM logoWhy Abbott Laboratories (ABT) Stock Is Up Today - (NYSE:ABT) - August 25 at 3:15 PM logoCarson Block Takes on St. Jude Medical Claiming Hack Risk (NYSE:ABT) - August 25 at 3:15 PM logoWill MedSec's St.Jude Claims Impact Abbott Deal? (NYSE:ABT) - August 25 at 3:15 PM logoWhy Abbott Laboratories (ABT) Stock Is Up Today (NYSE:ABT) - August 25 at 3:15 PM
News IconAbbott Laboratories (NYSE:ABT) from Medical Appliances ... - Twin County News (NYSE:ABT) - August 25 at 8:02 AM
News IconHC Stocks Broker Alerts: MannKind Corporation (MNKD), Abbott Laboratories (ABT) - share market updates (press release) (NYSE:ABT) - August 25 at 8:02 AM logoAbbott to Present at Wells Fargo Healthcare Conference (NYSE:ABT) - August 24 at 11:34 AM
News IconAnalyst Perspectives on Price Target History: Abbott Laboratories (NYSE:ABT) - Post Registrar (NYSE:ABT) - August 23 at 3:13 PM logoHere’s The Growth Forecast For Abbott Laboratories (NYSE:ABT) (NYSE:ABT) - August 23 at 9:52 AM
News IconAbbott Laboratories's (ABT): Watch List - Hot Stocks Point (NYSE:ABT) - August 22 at 3:16 PM logoPfizer spends $14B on Medivation in cancer fight (NYSE:ABT) - August 22 at 3:16 PM logoWill Abbott Laboratories (NYSE:ABT) Hit $52 Price Target? - Investor Newswire (NYSE:ABT) - August 22 at 8:02 AM
News IconMedical Appliances & Equipment: Abbott Laboratories (NYSE:ABT) Position of the day (NYSE:ABT) - August 20 at 8:40 AM logoEdwards Lifesciences Taking The Surgery Out Of Heart Surgery (NYSE:ABT) - August 19 at 11:29 AM
News IconHealthcare Stocks Charging Up for Historic Highs: Abbott Laboratories (ABT), Teva Pharmaceutical (NYSE:TEVA) - Street Wise Report (press release) (blog) (NYSE:ABT) - August 18 at 8:40 PM logoHow BSX Plans to Accelerate Its Neuromodulation Market Position (NYSE:ABT) - August 18 at 8:40 PM
News IconHC Stocks Broker Alerts: MannKind Corporation (NASDAQ:MNKD), Abbott Laboratories (NYSE:ABT) - share market updates (press release) (NYSE:ABT) - August 18 at 3:15 PM
News IconAbbott Laboratories's (ABT): Trending Stock - Hot Stocks Point (NYSE:ABT) - August 18 at 3:15 PM logo10 value stocks that have become more attractive in the past year (NYSE:ABT) - August 17 at 3:16 PM
News IconDelaney Dennis R buys $1834977 stake in Abbott Laboratories (ABT) (NYSE:ABT) - August 17 at 11:30 AM
News IconTop Gainers of the Day: Abbott Laboratories (NYSE:ABT) from Medical Appliances & Equipment (NYSE:ABT) - August 16 at 8:35 PM logoSee Which Of The Latest 13F Filers Holds Abbott Laboratories (NYSE:ABT) - August 15 at 3:17 PM logoAbbott Laboratories (ABT) Crosses Pivot Point Support at $44.82 (NYSE:ABT) - August 12 at 11:49 AM logoAbbott Labs Salesman Commits Suicide, Cites Company Pressure To Hit Sales Targets (NYSE:ABT) - August 11 at 9:06 PM
News IconHC Stocks Newsbeat: Abbott Laboratories (ABT), Agilent Technologies Inc (A) - share market updates (press release) (NYSE:ABT) - August 10 at 3:26 PM logoAbbott Laboratories (ABT) Stock Declines, Alere Deal Looks Uncertain - (NYSE:ABT) - August 10 at 3:25 PM logoABBOTT LABORATORIES Financials (NYSE:ABT) - August 10 at 3:25 PM logoSchaper Benz Wise Investment Counsel Incwi buys $9,137,975 stake in Abbott Laboratories (ABT) (NYSE:ABT) - August 10 at 11:49 AM logoAbbott Laboratories (ABT) Stock Declines, Alere Deal Looks Uncertain (NYSE:ABT) - August 10 at 11:49 AM logoWhat Analysts Recommend for Becton Dickinson after 3Q16 Earnings (NYSE:ABT) - August 10 at 11:49 AM logo3 Reasons Behind Abbott Laboratories' 14% Move Higher in July (NYSE:ABT) - August 9 at 1:25 PM
News IconIs Abbott Laboratories (NYSE:ABT), a large market cap stock a smart buy? (NYSE:ABT) - August 9 at 11:59 AM logoSupplemental Annuity Collective Trust Of Nj buys $1,078,800 stake in Abbott Laboratories (ABT) (NYSE:ABT) - August 9 at 11:59 AM
News IconAnalysts Estimates and Ratings: Abbott Laboratories (NYSE:ABT) (NYSE:ABT) - August 9 at 11:59 AM logoBecton Dickinson’s BD Life Sciences in Fiscal 3Q16: Strong Growth (NYSE:ABT) - August 9 at 11:59 AM
News IconHC Stocks in the Rumor: Abbott Laboratories (NYSE:ABT) PTC Therapeutics, Inc. (NASDAQ:PTCT) - share market updates (press release) (NYSE:ABT) - August 8 at 8:43 PM logoAlere Files Delayed 2015 Results, Fight With Abbott Goes On (NYSE:ABT) - August 8 at 3:15 PM logo​Analyst: Abbott probably can’t back out of its $5.8B offer to buy Alere (NYSE:ABT) - August 8 at 3:15 PM logoPreview of Analysts Recommendation: Abbott Laboratories (NYSE:ABT) , Brookdale Senior Living Inc. (NYSE:BKD) - Street Updates (NYSE:ABT) - August 8 at 8:02 AM logoMara Abbott’s Beautiful Ride in Rio (NYSE:ABT) - August 8 at 8:02 AM logoStrong Sell Calls For Abbott Laboratories (NYSE:ABT) At 0 - Investor Newswire (NYSE:ABT) - August 7 at 3:16 PM
News IconIntegrated Wealth Management Lowers stake in Abbott Laboratories (ABT) (NYSE:ABT) - August 7 at 5:58 AM


Abbott Laboratories (NYSE:ABT) Chart for Friday, August, 26, 2016

Last Updated on 8/26/2016 by Staff